Search

Your search keyword '"Everlof, Gerry"' showing total 17 results

Search Constraints

Start Over You searched for: Author "Everlof, Gerry" Remove constraint Author: "Everlof, Gerry" Database Unpaywall Remove constraint Database: Unpaywall
17 results on '"Everlof, Gerry"'

Search Results

3. Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1H-pyrazol-1-yl)methyl)phosphonate (BMS-820132)

4. Development of BET inhibitors as potential treatments for cancer: A new carboline chemotype

5. Discovery of an Oxycyclohexyl Acid Lysophosphatidic Acid Receptor 1 (LPA1) Antagonist BMS-986278 for the Treatment of Pulmonary Fibrotic Diseases

6. Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design

7. Development of BET inhibitors as potential treatments for cancer: A search for structural diversity

8. Abstract 5789: Discovery of clinical candidate BMS-986158, an oral BET inhibitor, for the treatment of cancer

9. Discovery of ((4-(5-(Cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carbonyl)(propyl)carbamoyloxy)methyl-2-(4-(phosphonooxy)phenyl)acetate (BMS-751324), a Clinical Prodrug of p38α MAP Kinase Inhibitor

10. Discovery of Clinical Candidate BMS-906024: A Potent Pan-Notch Inhibitor for the Treatment of Leukemia and Solid Tumors

11. Abstract 1643: BMS-983970, an oral pan-Notch inhibitor for the treatment of cancer

12. Discovery of 5-Chloro-4-((1-(5-chloropyrimidin-2-yl)piperidin-4-yl)oxy)-1-(2-fluoro-4-(methylsulfonyl)phenyl)pyridin-2(1H)-one (BMS-903452), an Antidiabetic Clinical Candidate Targeting GPR119

13. 4-Benzothiazole-7-hydroxyindolinyl Diaryl Ureas Are Potent P2Y1Antagonists with Favorable Pharmacokinetics: Low Clearance and Small Volume of Distribution

14. Reductions in log P Improved Protein Binding and Clearance Predictions Enabling the Prospective Design of Cannabinoid Receptor (CB1) Antagonists with Desired Pharmacokinetic Properties

15. Discovery of diarylurea P2Y1 antagonists with improved aqueous solubility

16. Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor

Catalog

Books, media, physical & digital resources